First Trust Advisors’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
|
|||||
2023
Q2 | $6.8M | Sell |
|
|||||
2023
Q1 | $50.8M | Sell |
|
|||||
2022
Q4 | $47.7M | Sell |
|
|||||
2022
Q3 | $47.2M | Sell |
|
|||||
2022
Q2 | $43.1M | Buy |
|
|||||
2022
Q1 | $41.8M | Sell |
|
|||||
2021
Q4 | $75M | Buy |
|
|||||
2021
Q3 | $43.6M | Buy |
|
|||||
2021
Q2 | $82.7M | Buy |
|
|||||
2021
Q1 | $56.6M | Buy |
|
|||||
2020
Q4 | $52.6M | Sell |
|
|||||
2020
Q3 | $68.7M | Sell |
|
|||||
2020
Q2 | $68.3M | Buy |
|
|||||
2020
Q1 | $45.8M | Buy |
|
|||||
2019
Q4 | $56.1M | Sell |
|
|||||
2019
Q3 | $48.5M | Sell |
|
|||||
2019
Q2 | $92.4M | Buy |
|
|||||
2019
Q1 | $103M | Buy |
|
|||||
2018
Q4 | $79M | Buy |
|
|||||
2018
Q3 | $100M | Buy |
|
|||||
2018
Q2 | $75.1M | Buy |
|
|||||
2018
Q1 | $46.4M | Buy |
|
|||||
2017
Q4 | $36.8M | Buy |
|
|||||
2017
Q3 | $3.61M | Buy |
|
|||||
2017
Q2 | $599K | Buy |
|
|||||
2016
Q1 | – | Sell |
|
|||||
2015
Q4 | $311K | Buy |
|